Three STDs Hit All-Time High in 2017 in USA

28 August 2018
Medscape

Preliminary data indicate that rates of three sexually transmitted diseases (STDs) — Chlamydia infection, gonorrhea, and syphilis — hit an all-time high in 2017, according to the US Centers for Disease Control and Prevention (CDC).

The CDC said that the United States is on track to have 1.7 million cases of Chlamydiainfection (up from 1.59 million in 2016), 555,608 cases of gonorrhea, and 30,644 cases of primary and secondary syphilis in 2017. Overall, that's 200,000 more cases of the three reportable STDs than in 2016, and it's the fourth year in a row that the United States has had a significant increase in those conditions.

The early data indicate that from 2013 to 2017, the number of gonorrhea cases increased by 67% and syphilis cases nearly doubled, said Gail Bolan, MD, director of the CDC's Division of STD Prevention, in a call with reporters. A significant number of the syphilis cases — 17,736 — were in men who have sex with men. The figures are alarming, said Bolan and other officials who participated in the call.

Comments

Green tea ingredient may ameliorate memory impairment, brain insulin resistance, and obesity

Federation of American Societies for Experimental Biology A study published online in The FASEB Journal, involving mice, suggests that EGCG (epigallocatechin-3-gallate), the most abundant catechin and biologically active component in green tea, could alleviate high-fat and high-fructose (HFFD)-induced insulin resistance and cognitive impairment. Previous research pointed to the potential of EGCG to treat a variety of human diseases, yet until now, EGCG's impact on insulin resistance and cognitive deficits triggered in the brain by a Western diet remained unclear. Journal Reference: Yashi Mi, Guoyuan Qi, Rong Fan, Qinglian Qiao, Yali Sun, Yuqi Gao, Xuebo Liu. EGCG ameliorates high-fat– and high-fructose–induced cognitive defects by regulating the IRS/AKT and ERK/CREB/BDNF. The FASEB Journal, 2017; fj.201700400RR DOI: 10.1096/fj.201700400RR

How healthy is genetically modified soybean oil?

University of California-Riverside Soybean oil accounts for more than 90 percent of all the seed oil production in the United States. Genetically modified soybean oil, made from seeds of GM soybean plants, was recently introduced into the food supply on the premise that it is healthier than conventional soybean oil. But is that premise true? Just barely, say scientists. Researchers at the University of California, Riverside have tested a genetically-modified (GM) soybean oil used in restaurants and found that while it induces less obesity and insulin resistance than conventional soybean oil, its effects on diabetes and fatty liver are similar to those of conventional soybean oil.

Eagle Eye Science

Search This Blog